How does KFLG's PB Ratio compare to its peers?

Insufficient data to calculate KFLG's Price-To-Book Ratio vs. peers for valuation analysis.

How does KFLG's PB Ratio compare vs other companies in the European Healthcare Industry?

Insufficient data to calculate KFLG's Price-To-Book Ratio vs. industry for valuation analysis.

What is KFLG's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate KFLG's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of KFLG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate KFLG's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

KFLG Stock Overview

Kemofarmacija d. d. engages in the wholesale distribution of medicinal products and medical devices to healthcare systems, pharmacies, and hospitals in Slovenia. More details

KFLG fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Shares are highly illiquid

Has not reported any financial data

Does not have a meaningful market cap (€70M)

My Notes

Capture your thoughts, links and company narrative

Kemofarmacija d. d. Competitors

SALUS Ljubljana d. d

LJSE:SALR

€221.3m

OLBA HEALTHCARE HOLDINGS

TSE:2689

JP¥11.8b

Professional Medical Expertise

SASE:9574

ر.س312.9m

Ohki Healthcare HoldingsLtd

TSE:3417

JP¥10.9b

Price History & Performance

Summary of share price highs, lows and changes for Kemofarmacija d. d
Historical stock prices
Current Share Price	€79.00
52 Week High	€79.00
52 Week Low	€52.00
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	255.86%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	KFLG	SI Healthcare	SI Market
7D	0%	-0.8%	0.08%
1Y	n/a	2.5%	32.0%

Return vs Industry: Insufficient data to determine how KFLG performed against the SI Healthcare industry.

Return vs Market: Insufficient data to determine how KFLG performed against the SI Market.

Price Volatility

Is KFLG's price volatile compared to industry and market?
KFLG volatility
KFLG Average Weekly Movement	n/a
Healthcare Industry Average Movement	4.3%
Market Average Movement	2.3%
10% most volatile stocks in SI Market	4.7%
10% least volatile stocks in SI Market	1.5%

Stable Share Price: KFLG has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine KFLG's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1947	n/a	Davorin Poherc	www.kemofarmacija.si

Kemofarmacija d. d. engages in the wholesale distribution of medicinal products and medical devices to healthcare systems, pharmacies, and hospitals in Slovenia. It offers food supplements, cosmetic products, chemicals, and other services for pharmacies. The company also provides services for the import of unregistered medicines, logistical support in implementation of clinical trials, and warehousing and logistics.

Kemofarmacija d. d. Fundamentals Summary

How do Kemofarmacija d. d's earnings and revenue compare to its market cap?
KFLG fundamental statistics
Market cap	€69.62m
Earnings (TTM)	€0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is KFLG overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
KFLG income statement (TTM)
Revenue	€0
Cost of Revenue	€0
Gross Profit	€0
Other Expenses	€0
Earnings	€0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did KFLG perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/08/06 21:49
End of Day Share Price	2023/05/09 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kemofarmacija d. d. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution